Search results
Viatris closes $3.37bn divestitures with OTC deal
Pharmaceutical Technology· 11 hours agoViatris announced the finalisation of a transaction to divest its over-the-counter (OTC) business, completing the last step in its previously declared...
Buy Biocon; target of Rs 400: Sharekhan
CNBC Awaaz· 4 days agoSharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 400 in its research report dated June 28, 2024.